[Drug therapy of tuberculosis].
D000577:Amides / Q000008:administration & dosage; D000636:Aminosalicylic Acids / Q000008:administration & dosage; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002207:Capreomycin / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000008:administration & dosage; D005000:Ethionamide / Q000008:administration & dosage; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage; D007539:Isonicotinic Acids / Q000008:administration & dosage; D007612:Kanamycin / Q000008:administration & dosage; D010670:Phenylthiourea / Q000008:administration & dosage / Q000031:analogs & derivatives; D011718:Pyrazinamide / Q000008:administration & dosage; D012293:Rifampin / Q000008:administration & dosage; D013307:Streptomycin / Q000008:administration & dosage; D013752:Tetracycline / Q000008:administration & dosage; D013882:Thiosemicarbazones / Q000008:administration & dosage; D014376:Tuberculosis / Q000188:drug therapy*; D014756:Viomycin / Q000008:administration & dosage
D000577:Amides; D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D007539:Isonicotinic Acids; D013882:Thiosemicarbazones; D002207:Capreomycin; D011718:Pyrazinamide; D007612:Kanamycin; D010670:Phenylthiourea; D004977:Ethambutol; D013752:Tetracycline; D005000:Ethionamide; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin; D014756:Viomycin
Medikamentöse Behandlung der Tuberkulose